Purpose: The living arrangements of elderly persons can play a crucial role in their health.This study evaluated the association between living arrangements and frailty among elderly Korean men. Methods: The cross-sectional data from the Korea National Health and Nutrition Examination Survey (2014–2019) were used. A total of 3,198 men aged 65 years or older were divided into a living alone group (LA, n = 393) and a not living alone group (NLA, n = 2,805). The dietary intake data was obtained from a single 24-hour recall. The food variety score (FVS) was defined as the number of foods items consumed in one day. Frailty was defined as the presence of three or more of the modified Fried frailty phenotype criteria. The association between living arrangements and frailty was analyzed by multiple nominal logistic regression. Results: The LA group showed significantly lower FVSs than the NLA group. The intakes of fruit, vegetables, fish and shellfish, fiber, and key antioxidant nutrients such as vitamins A and C, were lower in LA than in NLA. Multiple nominal logistic regression revealed a higher odds ratio (OR) for frailty in the LA group compared to the NLA group (OR [95% confidence interval], 2.05 [1.12–3.74]; p = 0.019). Conclusion These findings suggest that the increased risk of frailty among elderly men living alone may be partially associated with their lower dietary variety, particularly reduced intake of essential nutrients from fruit, vegetables, fish, and shellfish, highlighting their vulnerability to suboptimal nutrition. Thus, increasing diversity in food intake could be a useful dietary strategy to prevent the frailty of the living alone elderly.

Atopic dermatitis is the most common chronic inflammatory skin disease in children and adolescents. The Korean Academy of Pediatric Allergy and Respiratory Disease published the Atopic Dermatitis Treatment Guideline in 2008, which has been helpful in atopic dermatitis treatment until now. Various reports on the development and effectiveness of new drugs have suggested that there is a need to develop and revise old treatment guidelines. Part 1 aimed to provide evidence-based recommendations for skin care management and topical treatment for atopic dermatitis. Part 2 focuses on systemic treatment, novel therapeutics, and adjuvant therapy. The goal of this guideline is intended to assist front-line doctors treating pediatric and adolescent atopic dermatitis patients make safer, more effective, and more rational decisions regarding systemic treatment, novel therapeutics, and adjuvant therapy by providing evidence-based recommendations with a clear level of evidence and benefit regarding treatment.

Atopic dermatitis is the most common chronic inflammatory skin disease in children and adolescents. The Korean Academy of Pediatric Allergy and Respiratory Disease published the Atopic Dermatitis Treatment Guideline in 2008, which has been helpful in atopic dermatitis treatment until now. Various reports on the development and effectiveness of new drugs have suggested that there is a need to develop and revise old treatment guidelines. Part 1 aimed to provide evidence-based recommendations for skin care management and topical treatment for atopic dermatitis. Part 2 focuses on systemic treatment, novel therapeutics, and adjuvant therapy. The goal of this guideline is intended to assist front-line doctors treating pediatric and adolescent atopic dermatitis patients make safer, more effective, and more rational decisions regarding systemic treatment, novel therapeutics, and adjuvant therapy by providing evidence-based recommendations with a clear level of evidence and benefit regarding treatment.

Atopic dermatitis is the most common chronic inflammatory skin disease in children and adolescents. The Korean Academy of Pediatric Allergy and Respiratory Disease published the Atopic Dermatitis Treatment Guideline in 2008, which has been helpful in atopic dermatitis treatment until now. Various reports on the development and effectiveness of new drugs have suggested that there is a need to develop and revise old treatment guidelines. Part 1 aimed to provide evidence-based recommendations for skin care management and topical treatment for atopic dermatitis. Part 2 focuses on systemic treatment, novel therapeutics, and adjuvant therapy. The goal of this guideline is intended to assist front-line doctors treating pediatric and adolescent atopic dermatitis patients make safer, more effective, and more rational decisions regarding systemic treatment, novel therapeutics, and adjuvant therapy by providing evidence-based recommendations with a clear level of evidence and benefit regarding treatment.

Atopic dermatitis is the most common chronic inflammatory skin disease in children and adolescents. The Korean Academy of Pediatric Allergy and Respiratory Disease published the Atopic Dermatitis Treatment Guideline in 2008, which has been helpful in atopic dermatitis treatment until now. Various reports on the development and effectiveness of new drugs have suggested that there is a need to develop and revise old treatment guidelines. Part 1 aimed to provide evidence-based recommendations for skin care management and topical treatment for atopic dermatitis. Part 2 focuses on systemic treatment, novel therapeutics, and adjuvant therapy. The goal of this guideline is intended to assist front-line doctors treating pediatric and adolescent atopic dermatitis patients make safer, more effective, and more rational decisions regarding systemic treatment, novel therapeutics, and adjuvant therapy by providing evidence-based recommendations with a clear level of evidence and benefit regarding treatment.

Atopic dermatitis is the most common chronic inflammatory skin disease in children and adolescents. The Korean Academy of Pediatric Allergy and Respiratory Disease published the Atopic Dermatitis Treatment Guideline in 2008, which has been helpful in atopic dermatitis treatment until now. Various reports on the development and effectiveness of new drugs have suggested that there is a need to develop and revise old treatment guidelines. Part 1 aimed to provide evidence-based recommendations for skin care management and topical treatment for atopic dermatitis. Part 2 focuses on systemic treatment, novel therapeutics, and adjuvant therapy. The goal of this guideline is intended to assist front-line doctors treating pediatric and adolescent atopic dermatitis patients make safer, more effective, and more rational decisions regarding systemic treatment, novel therapeutics, and adjuvant therapy by providing evidence-based recommendations with a clear level of evidence and benefit regarding treatment.

Purpose: The living arrangements of elderly persons can play a crucial role in their health.This study evaluated the association between living arrangements and frailty among elderly Korean men. Methods: The cross-sectional data from the Korea National Health and Nutrition Examination Survey (2014–2019) were used. A total of 3,198 men aged 65 years or older were divided into a living alone group (LA, n = 393) and a not living alone group (NLA, n = 2,805). The dietary intake data was obtained from a single 24-hour recall. The food variety score (FVS) was defined as the number of foods items consumed in one day. Frailty was defined as the presence of three or more of the modified Fried frailty phenotype criteria. The association between living arrangements and frailty was analyzed by multiple nominal logistic regression. Results: The LA group showed significantly lower FVSs than the NLA group. The intakes of fruit, vegetables, fish and shellfish, fiber, and key antioxidant nutrients such as vitamins A and C, were lower in LA than in NLA. Multiple nominal logistic regression revealed a higher odds ratio (OR) for frailty in the LA group compared to the NLA group (OR [95% confidence interval], 2.05 [1.12–3.74]; p = 0.019). Conclusion These findings suggest that the increased risk of frailty among elderly men living alone may be partially associated with their lower dietary variety, particularly reduced intake of essential nutrients from fruit, vegetables, fish, and shellfish, highlighting their vulnerability to suboptimal nutrition. Thus, increasing diversity in food intake could be a useful dietary strategy to prevent the frailty of the living alone elderly.

Purpose: The living arrangements of elderly persons can play a crucial role in their health.This study evaluated the association between living arrangements and frailty among elderly Korean men. Methods: The cross-sectional data from the Korea National Health and Nutrition Examination Survey (2014–2019) were used. A total of 3,198 men aged 65 years or older were divided into a living alone group (LA, n = 393) and a not living alone group (NLA, n = 2,805). The dietary intake data was obtained from a single 24-hour recall. The food variety score (FVS) was defined as the number of foods items consumed in one day. Frailty was defined as the presence of three or more of the modified Fried frailty phenotype criteria. The association between living arrangements and frailty was analyzed by multiple nominal logistic regression. Results: The LA group showed significantly lower FVSs than the NLA group. The intakes of fruit, vegetables, fish and shellfish, fiber, and key antioxidant nutrients such as vitamins A and C, were lower in LA than in NLA. Multiple nominal logistic regression revealed a higher odds ratio (OR) for frailty in the LA group compared to the NLA group (OR [95% confidence interval], 2.05 [1.12–3.74]; p = 0.019). Conclusion These findings suggest that the increased risk of frailty among elderly men living alone may be partially associated with their lower dietary variety, particularly reduced intake of essential nutrients from fruit, vegetables, fish, and shellfish, highlighting their vulnerability to suboptimal nutrition. Thus, increasing diversity in food intake could be a useful dietary strategy to prevent the frailty of the living alone elderly.

Although glycopeptides remain the preferred treatment for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, the treatment of persistent MRSA bacteremia has been challenging. We investigated real-world treatment strategies for persistent MRSA bacteremia, with a specific emphasis on the use of antimicrobial agents and the frequency of changes during the treatment course. We retrospectively identified patients with persistent MRSA bacteremia in four university-affiliated hospitals between 2017 and 2021. The primary objective of this study was to investigate the patterns of antimicrobial uses for MRSA bacteremia. The secondary objectives were evaluating the associated factors with 1) overall 30-day mortality and 2) changing agents during the treatment course. Time-dependent Cox regression analysis was used to adjust for immortal time bias. Among 116 patients, 37.1% underwent antimicrobials switching, primarily prompted by persistent bacteremia. The 30-day mortality rates of groups with and without antimicrobial switching were 21.4% and 44.2%, respectively (p=0.010 by log-rank test); however, after adjustment for immortal time bias, there was no statistical significance between the two groups (adjusted hazard ratio 0.24, 95% confidence interval 0.03–2.17, p=0.238). Only the Pitt bacteremia score on day 4 and pneumonia were associated with 30-day mortality. Meanwhile, the factors associated with antimicrobial switching were the duration of bacteremia, the initial use of teicoplanin, echocardiogram, and Charlson comorbidity index. This study showed that while over one-third of persistent MRSA bacteremia patients experience changes in antimicrobial agents during treatment, this practice does not significantly improve the 30-day mortality. Our study suggests the need for more effective treatment strategies in managing persistent MRSA bacteremia.

Purpose: Accumulating evidence suggests that seafood and its components, such as eicosapentaenoic acid and docosahexaenoic acid, are known to prevent cardiovascular disease (CVD). However, little is known about whether sleep quality, which has been recognized as a risk factor for CVD, might influence these associations. Therefore, the purpose of the study was to investigate the longitudinal associations between seafood consumption and CVD in Korean adults with or without insomnia. Methods: The data were collected from the Korean Genome and Epidemiology Study (KoGES) and included 3,168 participants aged 40–69 years. Dietary intake was measured by a validated 106-item food-frequency questionnaire, and insomnia was assessed using a questionnaire on sleep-related symptoms. The CVD events included myocardial infarction, coronary artery disease, congestive heart failure, cerebrovascular disease, and peripheral vascular disease. Associations of seafood consumption with CVD were assessed using timedependent Cox regression analyses to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) while adjusting for potential confounding factors. Results: During the 8-year follow-up period, the incidence of CVD was 5.1%. There was a positive association between seafood consumption and most food groups, as well as nutrients. In contrast, as seafood consumption increased, the consumption of grains decreased. Regarding nutrient intake, there was a negative association between seafood consumption and carbohydrate intake. After adjustment for confounding factors, the risk of CVD was inversely associated with seafood consumption, with a 56% lower risk (HRT3 vs. T1 , 0.44; 95% CI, 0.26–0.75; p = 0.002), only in the non-insomnia group. Conclusion Findings from this study suggest that seafood consumption might lead to more favorable outcomes against CVD if accompanied by good sleep quality.